Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has decided to leave the company as of February 28, ...
Learn more about modern pharmaceuticals and how sometimes they are able to treat more than one type of illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results